1-7F9 anti-KIR antibody

anti-KIR monoclonal antibody 1-7F9 · Innate Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 1-7F9 anti-KIR antibody, covering 2012-06-28 to 2012-06-28. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma [Phase 1]

See pricing